CMS became the first securities company clearing member of CME Group in mainland China via its subsidiary, China Merchants Futures (HK)

CMS (2013-11-27 14:01) [Full Text]

 

CMS won the first mainland China securities company clearing membership of CME Group by way of its subsidiary, China Merchants Futures (HK), opening up a channel for mainland China's brokers to provide overseas commodity risk hedging products and services for commodities and resources enterprises in China.

On October 21, China Merchants Futures (HK), a subsidiary of CMS, qualified for the first mainland China securities company clearing membership of CME Group (including CME, CBOT, COMEX and NYMEX). Thus CMS opened up a channel for mainland China's brokers to provide China's commodities and resources enterprises with overseas commodity risk hedging products and services, shattering the history of domestic commodity risk hedging field monopolized by foreign financial institutions. This is also a landmark breakthrough achieved by CMS in the field of innovative development and international operation.

Why CMS can stand out from the its peers in mainland China and obtain the clearing membership in the highly competitive international commodity market? Riwei Chen, CEO of China Merchants Futures (HK), expressed that, the obtaining of the clearing qualification depended on that CMS had insight into the huge demand of domestic enterprises for hedging against overseas commodity risk and made full use of the international business management and risk control experience accumulated through its Hong Kong business platform.

CMS's overseas institutions are currently under construction, intending to launch businesses of other international commodity exchanges besides CME, with a goal to provide clients with worldwide, one-stop global commodities and services in the near future, thus further enhancing the core competitiveness of the company's diversified and international platform.

【Disclaimer】

The recommended or reviewed securities in this comment doesn’t have any stake in the interest of the company and authors. Analysis of the company and individuals in this website cannot be used as any decision support but consultant for investment.